Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Adenine single-base editing product without PAM limitation, method and application

A single-base, gene-editing technology, applied in the fields of genetic engineering and protein modification, can solve problems such as editing efficiency limitations and achieve good application prospects

Pending Publication Date: 2022-05-31
EAST CHINA NORMAL UNIV +1
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although the corresponding mutation on the complementary strand of the mutation site is theoretically repairable by ABE (G>A), since the region on the complementary strand including the mutation site (G>A) is not suitable for ABE7. PAM, coupled with the limitation of ABE7.10 editing efficiency in hematopoietic stem / progenitor cells, has been unable to achieve effective repair of this pathogenic mutation by single base editing

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Adenine single-base editing product without PAM limitation, method and application
  • Adenine single-base editing product without PAM limitation, method and application
  • Adenine single-base editing product without PAM limitation, method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0072] Example 1. Guided by NGG PAM sgRNA and non-NGG PAM sgRNA respectively in healthy human hematopoietic stem / progenitor cells to achieve efficient introduction of A>G substitution at the target site (taking the electroporation delivery method as an example)

[0073] The healthy human hematopoietic stem / progenitor cells used in this example come from the peripheral blood of healthy people.

[0074] 1. Design of sgRNA

[0075] Design a non-NGG PAM sgRNA at the NACT-2 site in the intergenic region of the normal site, numbered sgNACT-2 (PAM is GGCT), and its targeting sequence is:

[0076] sgNACT-2: (SEQ ID No. 5);

[0077] Design an NGG PAM sgRNA in the normal site BCL11A gene enhancer region, numbered sg1620 (PAM is GGG), and its targeting sequence is:

[0078] sg1620: (SEQ ID No. 6);

[0079] Among them, the above two target sequences are both 20bp in length, and A in the ABE-SPRY editing window is located at the bold horizontal line mark in the above sequence.

[0...

Embodiment 2

[0109] Example 2. Repair of disease-causing sites in β-thalassemia IVS2-654 C>T-deficient hematopoietic stem / progenitor cells (taking electroporation as an example)

[0110] The β-thalassemia IVS2-654 C>T-deficient hematopoietic stem / progenitor cells used in this example came from patients heterozygous for β-thalassemia IVS2-654.

[0111] 1. Design of sgRNA

[0112] Design non-NGG PAM sgRNAs within 20 bp including the abnormal splicing mutation IVS2-654 C>T site, numbered IVS2-654-sg1 to IVS2-654-sg5, and the target sequences are:

[0113] IVS2-654-sg1: (SEQ ID No.7, PAM is TCA);

[0114] IVS2-654-sg2: (SEQ ID No.8, PAM is ATC);

[0115] IVS2-654-sg3: (SEQ ID No.9, PAM is TAT);

[0116] IVS2-654-sg4: (SEQ ID No.10, PAM is TTA);

[0117] IVS2-654-sg5: (SEQ ID No.11, PAM is ATT);

[0118] Among them, the above five targeting sequences are all 20bp in length, and the IVS2-654 C>T mutation site (the complementary strand is A, located at the bold horizontal line mark...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a PAM limitation-free adenine single base editing product, a PAM limitation-free adenine single base editing method and an application of the PAM limitation-free adenine single base editing product. The product comprises a fusion protein, the fusion protein comprises the following two parts: adenine nucleoside deaminase and endonuclease, the amino acid sequence of the adenine nucleoside deaminase comprises a sequence as shown in SEQ ID No.1, and the amino acid sequence of the endonuclease comprises a sequence as shown in SEQ ID No.2. The product can realize the introduction of Agt without PAM limitation into the genes of cells, especially hematopoietic stem / progenitor cells; g, replacement editing is carried out, the edited autologous hematopoietic stem cells of the patient are transfused back, and the purpose of thoroughly curing diseases in a long-acting mode can be achieved. The product is applied to repair of beta-thalassemia (thalassemia) related mutation IVS2-654 Cgt; the beta-globin gene editing efficiency is high, the expression level of the beta-globin gene can be remarkably and effectively improved, and the beta-globin gene editing method has the application potential in clinical treatment of beta-anemia.

Description

technical field [0001] The present invention relates to the technical field of genetic engineering and protein transformation, in particular to a product, method and application of adenine single base editing without PAM restriction. Background technique [0002] The CRISPR / Cas9 gene editing system can cut at a specific part of DNA to generate a DNA double-strand break (DSB), and there are two repair mechanisms in the cell, non-homologous end joining and homologous recombination repair, so as to realize genome editing. But the original CRISPR technology involves DNA double-strand breaks, which pose potential risks. The development of a single-base gene editing system can achieve precise modification of specific genetic loci without causing DNA double-strand breaks. The base editor in the single-base gene editing system is mainly composed of two parts: Cas protein and DNA modification enzyme. So far, two types of base editors have been developed: cytosine base editor (CBE),...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K19/00C12N9/22C12N9/78C12N15/62C12N15/87C12N5/10A61K38/50A61P7/06A61K38/46
CPCC12N9/22C12N9/78C12Y305/04004C12N15/87C12N5/0647C07K14/805A61K38/465A61K38/50A61P7/06C12N2510/00A61K2300/00Y02A50/30
Inventor 吴宇轩陈双红廖娇阳蒋艳红萧圣霖刘明耀席在喜
Owner EAST CHINA NORMAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com